Skip to content

Economic evaluation of the BabblePlay app intervention to support early vocalising in infants with Down syndrome

Economic evaluation of the BabblePlay app intervention to support early vocalising in infants with Down syndrome: a cost-utility analysis alongside a randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN30044928
Enrollment
76
Registered
2026-04-30
Start date
2026-02-26
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down syndrome Other

Interventions

The intervention being evaluated is BabblePlay app, a novel, tablet-based behavioural intervention designed to support early vocal development in infants with Down syndrome. The intervention uses a co

Sponsors

University of York
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Months to 15 Months

Inclusion criteria

Inclusion criteria: Same as the BabblePlay RCT: 1. The infant has a diagnosis of Down syndrome 2. The infant is aged between 7 and 15 months at the point of randomisation 3. The infant is growing up in a monolingual English-speaking household, or is exposed to less than 10% of another language, based on caregiver report 4. The infant has eyesight good enough to view shapes on an iPad screen (based on caregiver report) 5. Twins (triplets/quadruplets/….) are eligible to participate 6. The family is based in the UK 7. The infant is not taking part in another speech, language or communication intervention research study

Exclusion criteria

Exclusion criteria: Same as the BabblePlay RCT: 1. Infant does not meet the diagnosis, age, language exposure, or residency requirements listed above 2. Infant has visual difficulties that would prevent them from seeing shapes on the iPad screen 3. Infant is currently in another speech, language, or communication intervention research study

Countries

England, United Kingdom

Contacts

Public ContactTamar Keren-Portnoy
tamar.keren-portnoy@york.ac.uk+44 (0)1904 323614

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 16, 2026